
The programme “36,9” from www.rts.ch, which is celebrating its 20th anniversary, has put together a retrospective of its episodes. The CIG features in it; watch from the 50-minute mark.

The programme “36,9” from www.rts.ch, which is celebrating its 20th anniversary, has put together a retrospective of its episodes. The CIG features in it; watch from the 50-minute mark.
Research integrity is not just about extreme misconduct — it is also about the human biases that insidiously push science from responsible practice toward questionable habits, undermining reproducibility and credibility.
This seminar offers concrete tools and strategies applicable at the bench and largely relevant to any researcher, whatever their field—including if you attended last year, as content has been updated.
In this year’s keynote lecture, Joe Garner (Stanford University) proposes a powerful mindset shift in experimental design illustrated by examples from animal research, but broadly applicable beyond the animal lab: moving from “what did we control?” to “what did we choose to ignore — and at what cost?”.
When, where
Who should attend?
Programme
Introduction : Research integrity – The Good, the Bad and the Ugly — Frédéric Preitner
Ethics at the bench (1): Managing bias in experimental design and data visualization — Frédéric Schutz
Ethics at the bench (2): Beautification, manipulation, and AI: ethics of scientific images — Romain-Daniel Gosselin
The FBM Ombudsman introduces himself —Christian Kern
Keynote lecture : Changing the scientific mindset in biomedical studies — Joe Garner (Stanford University)
About the keynote speaker
Joe Garner is Professor of Comparative Biomedicine at Stanford University, where his work on animal models and experimental design has made him one of the leading voices on reproducibility in biomedical research. His keynote challenges researchers to move beyond “what did we control?” and ask instead: “what did we choose to ignore — and at what cost?”
Further information about Joe Garner’s work
Beyond3Rs: https://med.stanford.edu/beyond3rs.html
Stanford website: med.stanford.edu/profiles/Joseph_Garner
Papers: scholar.google.com/citations?user=JThS8LMAAAAJ
Mouse ethogram: www.mousebehavior.org
Talk abstracts
If you’re working in AI and (bio)medical research and are aiming to start an independent research group, we believe VIB.AI offers a truly exceptional environment to do so, combining deep biological expertise with cutting-edge AI research, and strong ties to Ghent University and KU Leuven.
You’ll find more details in our flyer: https://vib.ai/recruitment
or on our website: https://vib.ai/en/group-leader-vacancy
__
Stein Aerts
Scientific Director and Group Leader
Professor KU Leuven
VIB.AI – VIB Center for AI & Computational Biology
Laboratory of Computational Biology

The AI@UNIL Day is a research‑focused scientific event that brings together UNIL’s AI research community and AI experts from neighboring academic institutions. The event aims to showcase the breadth of AI research conducted at UNIL as well as within regional academic institutions.
More than a scientific meeting, it provides a space for exchange and collaboration, highlighting how artificial intelligence serves as a shared language across disciplines and strengthens connections both within UNIL and with the broader regional research ecosystem.
Through interdisciplinary dialogue and shared expertise, the AI@UNIL Day supports the emergence of new collaborative projects and promotes a dynamic, responsible, and inclusive approach to AI research.
More information on: https://ai-day.unil.ch/
Michele Marconcini 1 , Caroline Fragnière 1 , Ambra Masuzzo 1 , Richard Benton 1
Affiliations
Many insects can rapidly evolve resistance to artificial insecticides through changes in toxin target proteins. Over longer timescales, insects also evolve resistance to naturally occurring toxins to exploit new ecological niches, but the underlying mechanisms often remain poorly understood. A classic example is Drosophila sechellia, an extreme specialist for the ripe noni fruit of Morinda citrifolia. Noni is toxic for other insects-including D. sechellia’s close relatives Drosophila simulans and Drosophila melanogaster-due to this fruit’s high content of octanoic acid (OA). However, the mechanistic bases of OA susceptibility and resistance across species remain unclear. Here, we first show that the species-specific tolerance of OA is independent of these drosophilids’ distinct microbiomes. Screening large, genetically diverse panels of D. melanogaster and D. simulans strains revealed broad variation in OA resistance, with some lines surviving as well as D. sechellia. Resistance to OA does not correlate with resistance of these lines to other insecticides, implying a distinct toxicity mode of action. Genome-wide association and transcriptome-to-phenotype analyses identified multiple genes linked to OA resistance, with diverse expression patterns and functions, including those involved in epithelial septate junction formation and lipid transport. Loss-of-function analysis in D. melanogaster confirmed that at least 2 of these-Bez, a CD36-family fatty acid transporter, and CG13003, a putative extracellular matrix component-positively contribute to OA resistance. Integration of our findings with those from previous complementary genetic approaches supports a model in which OA has no singular target, and that resistance is defined by multigenic and multitissue defense mechanisms.
Xavier Palomer 1 , Ricardo Rodríguez-Calvo 2 , Marta Tajes 3 , Walter Wahli 4 , Manuel Vázquez-Carrera 5
Affiliations
The most common dietary and plasma fatty acids (FAs), palmitic and oleic acids, have opposing effects on the risk of developing insulin resistance and type 2 diabetes mellitus (T2DM). Palmitic acid has been strongly associated with the presence of T2DM, while oleic acid has not and may even counteract the detrimental effects of palmitic acid. Despite this, recent cohort studies have shown no association or even conflicting results, questioning these roles. This review summarizes the recently discovered molecular mechanisms by which palmitic acid inhibits insulin sensitivity and influences the development and progression of T2DM and how oleic acid can attenuate these effects. It also addresses future challenges in the growing field of dietary FA metabolism in T2DM research, which may help assess their actual impact on this condition.